Easy Contact Form

Weight Loss Phoenix on BBB Weight Loss Phoenix on Facebook Phoenix Weight Loss Clinic on Twitter
Demand Force
Facebook
DISCLAIMER:
Results May Vary. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

The information, including but not limited to, text, graphics, images and other material, contained on this website is for educational purposes only. The content is not intended in any way as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment.

 

KYBELLA®


Say goodbye to your double chin.
Now offering FDA-approved KYBELLA!

SLIM DOWN YOUR DOUBLE CHIN WITHOUT SURGERY


79% In clinical studies, 79% of people treated with KYBELLA had improved satisfaction with the appearance of the area beneath their chin.


KYBELLA® is a manmade form of a substance that your body naturally makes to help absorb fat.  
KYBELLA® is administered by a physician in multiple small injections under the chin to help the apppearance of "DOUBLE CHINS".
KYBELLA® is for fat under the chin so is not ideal for those patients concerned with "loose" skin.
KYBELLA® kills the fat cells.  Once destroyed those cells cannot store or accumulate fat.

It typically requires 2-4 treatments but can require up to 6.  Treatments are 4-6 weeks apart and will be administered by our KYBELLA® trained physician.
Injections only take approximately 15-20 minutes per treatment.

What to expect:  After the first treatment, it is typical for patients to experience swelling, bruising and numbess in the chin area. This is to be expected.  Each following treatment, the side effects tend to be much less than the previous.  The pain will  likely only be mild or a moderate irritation.  No prescription pain medications are indicated and over the counter Acetaminophen (Tylenol) or ibuprofen will be sufficient to control any discomfort experienced from this treatment.

After reaching your desired aesthetic, NO FURTHER TREATMENTS are expected.
KYBELLA® (deoxycholic acid) injection 10 mg/mL Important Information
Indication
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults.
The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
Important Safety Information
Contraindications
KYBELLA® is contraindicated in the presence of infection at the injection sites.
Warnings and Precautions
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
Injection-Site Hematoma/Bruising
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.
Adverse Reactions
The most commonly reported adverse reactions in the pivotal clinical trials were: injection site edema/swelling, hematoma/bruising, pain, numbness, erythema, and induration.
Please see KYBELLA® full Prescribing Information at www.mykybella.com 
Top